Navigation Links
Weight reduction by 5% may help in treating nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in many countries. No proven treatment for patients with NAFLD is currently available//. Understanding the specific effects of weight reduction and lifestyle modifications in patients with NAFLD is important for patient counseling as well as for designing future clinical trials.

To deal with these issues, researchers from Mayo Clinic College of Medicine, Rochester, USA, and Kanazawa University Hospital, Ishikawa, Japan sought to determine the association of changes in body weight and lifestyle behaviors (exercise, alcohol consumption, and smoking) with changes in serum alanine aminotransferase (ALT), and the association between maintaining lifestyle modifications and persistently normal ALT levels.

In a study to be published in the next issue of the Journal of Hepatology, the researchers analyzed annual health checkup data from 1546 employees. Of 469 subjects with elevated ALT, they selected 348 male subjects by excluding those who had other causes of liver disease. They were followed for one year to assess the association of change in lifestyle with change in serum ALT. The 136 subjects who had ALT normalization were followed for two years to assess the association between lifestyle management and persistently normal ALT.

In the study, weight loss and regular exercise were significantly associated with improvement in serum ALT and increased the odds of ALT normalization, while starting smoking was significantly associated with deterioration in serum ALT. Subjects achieving ?Y5% weight reduction showed improvement in serum ALT. Maintaining reduced weight (<5% gain) was significantly associated with persistently normal ALT.

The results of the study indicate that reducing weight by at least 5% with subsequent weight control and exercising regularly may be beneficial in treating NAFLD. The information from this study is important for patient counseling and for the large population of individuals with hypertransaminasemia due to NAFLD.
'"/>




Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Weight-Loss Drinks Can Make You Gassy
3. Smoking Linked To Low Infant Birth Weight
4. Weight gain following smoking cessation not linked to Leptin
5. Helping Kids Attain a Healthy Weight
6. Weight-loss Products Dangerous
7. Weight and Blood Pressure
8. Low Birth Weight infants could have Problems in the Future
9. Excess Weight Can Affect Individuals as They Age
10. Low-Fat, High-Carb Diet Equally Effective In Weight Loss
11. Weight Gain Found To Increase The Risk Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... , ... "I had a terrible time trying to get my grandson to ... the nebulizer had a more child-friendly design, then children would be more likely to ... NEBY to avoid the need to deliver medication via a nebulizer mask. The design ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in ... and patient safety. Only a few hospitals and facilities have earned this distinction. ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for Input to ... Medical Informatics . , Results of the comparative usability study demonstrate that a ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... ... ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing announced today the ... their world headquarters of Omni La Costa Resort & Spa in San Diego. , ... loss, personal development, a healthy lifestyle, or mental and physical healing. The week-long wellness ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec 8, 2016 Research and Markets has announced ... report to their offering. ... This report analyzes the worldwide markets for Endodontic Supplies ... Canada , Japan , Europe ... Rest of World. Annual estimates and forecasts are provided for the ...
(Date:12/8/2016)... Dec. 8, 2016   TriNetX , the ... Children,s Hospital signed a membership agreement to ... development of new cures. The TriNetX ... 57 million patients globally, biopharmaceutical companies and contract ... improve protocol design, site selection, patient recruitment, and ...
(Date:12/8/2016)... 8, 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... today announced positive results from a Phase 3, ... the safety and efficacy of IDP-118 (halobetasol propionate ... psoriasis. Within the Phase 3 ... severe psoriasis, IDP-118 showed statistical significance to vehicle ...
Breaking Medicine Technology: